Tag Archives: 2011 BIO International Convention

Patents in the U.S. Supreme Court

joseph a

A special session at the 2011 BIO International Convention takes a fascinating look at the underlying factors involved in the U.S. Supreme Court hearing patent cases. The Supreme Court has been accepting patent cases at a higher rate than ever before, with three major patent appeals reviewed this past term alone.  And the Court seems poised to accept several more in the coming year. According to the session moderator, Chief Judge (Ret.) Paul Michel from Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , ,

2011 BIO International Convention: The evolution of one-on-one partnering

businessforum

From the beginning, networking has been a central focus at BIO’s events.  Our members attend our conferences primarily to seek out business opportunities and to meet other biotech executives. When company presentations were introduced at the 1998 BIO International Convention, delegates registered for the conference by mail and fax and presentations were the key means for companies to tell their stories at BIO’s early events.  With BIO members asking for introductions to pharmaceutical companies, BIO Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Bioenergy Business Outlook Survey Shows Bullish Market Expectations

Encouraged by the continued demand for alternative fuels, bioenergy executives are optimistic that their industry will be an increasingly investment-driven enterprise, according to the findings of the Summer 2011 Bioenergy Business Outlook survey.  The quarterly survey, co-sponsored by Biofuels Digest and BIO, was discussed at the BIO International Convention today by Jim Lane, editor of Biofuels Digest; Brent Erickson, Executive Vice President, BIO; and Adam Monroe, President, Novozymes North America. The survey reflects expectations for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Counterfeiting: White House IP Czar Victoria Espinel on working with corporations

Victoria Espinel

White house IP Czar Victoria Espinel spoke at BIO’s 2011 International Convention in a session titled Counterfeiting: How corporations and government can work together.  She told the audience that when entering her new assignment she was surprised to find out that counterfeiting was a large problem in the United States and not just abroad. The Administration has increased enforcement in counterfeit medicines as seizures of health related counterfeits have gone up 97% from last year.  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Innovative China: Policies for the Future

China Flag

As the second largest and fastest growing market for biotechnology products, China needs no introduction.  The opportunity to heal, fuel, and feed 1.3 billion global citizens stands in clear contrast with the regulatory, financial, and political frameworks that present challenges to the life science industry’s external access to the evolving Chinese market.  On Tuesday at the 2011 BIO International Convention, a panel discussion titled “Innovative China: Policies for the Future” addressed the future of the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,